![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Europe Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)
Market Introduction
The Europe Leukapheresis market is analyzed based on three large countries: Germany, the UK, France, Italy, Spain, and RoE. Germany is contributing a major share in the growth of leukapheresis market. Germany is an attractive market due to its steady growth and innovative approach to healthcare. According to the Federal Statistical Office, health expenditure in Germany in 2019 amounted to US$ 460.03 billion. The German medical device market is one of the largest in Europe and the third-largest in the world. The demand for highly innovative technologies and diagnostic, therapeutic, and minimally invasive devices remains high worldwide. Germany's medical device manufacturers can also apply for state funding for various research projects and receive grants from the Reconstruction Loan Corporation (KfW). Manufacturers' increasing focus on new product development and strategic collaborations to develop advanced diagnostic devices like leukapheresis is expected to fuel market growth. Germany has a strong health system, especially infrastructure, hospital beds, and trained staff. In 2018, according to the Ministry of Health, there were almost 498,400 beds in 1,925 hospitals, 1,142 rehabilitation centers, and 19,075 pharmacies. A well-developed infrastructure makes the health industry, with 5.6 million employees, the largest employer in Germany. In 2016, around 13,900 people in Germany contracted leukemia, 4% of them under 15. The risk decreases during the transition into young adulthood but increases again from the age of 30. These incidences are higher in men than in women. One in 67 men and one in 87 women will develop leukemia at some point in their lives.
The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Russia, Spain, Italy, Germany, France, and the UK are among the most affected European countries. Countries across Europe are witnessing a resurgence in COVID-19 cases after successfully mitigating outbreaks early in the year. Many countries are declaring more cases each day now than they were during the first wave earlier this year. Lockdowns are being reintroduced in UK, Spain and Italy, and Ireland, as per the European Centre for Disease Prevention and Control (ECDC). Due to the second wave of COVID-19 cases, the government of many countries is working towards scaling up testing capacity, which is driving the growth of the market.
![](https://www.theinsightpartners.com//assets/rdimages/25493-img1.png)
Get more information on this report :
Market Overview and Dynamics
The leukapheresis market in Europe is expected to grow from US$ 22.55 million in 2021 to US$ 39.26 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028. Therapeutic apheresis refers to an extracorporeal treatment that involves the selective removal of cells or other targeted abnormal substances from blood circulation. The technique has lately been explored for the treatment of various medical conditions. Extracorporeal photopheresis (ECP) is a process that is used in the treatment of lymphoma. In this process, white blood cells (WBCs) are collected from the bloodstream, treated with light-activated drugs, and exposed to UV lights, followed by infusing it back to the patient body. Therapeutic plasma exchange is a potential method employed to treat medical conditions such as multiple sclerosis, myeloma, and leukemia. The technique withdraws plasma from the patient’s blood and replaces it with fresh donor plasma or bottled human albumin solution. Further, the double filtration plasmapheresis technique is used for rapidly progressive glomerulonephritis and low-density lipoprotein (LDL) apheresis or leukocytapheresis for the nephritic syndrome. These techniques are two major apheresis therapies that are used to treat kidney diseases. Thus, the widening scope of apheresis technology in therapeutics is emerging as a prevalent trend in the leukapheresis market.
Key Market Segments
In terms of product type, the leukapheresis disposables segment held a larger share in 2021. Based on application, research applications segment held the largest share in 2021. Based on end user, blood component providers and blood centers segment held the largest share in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the leukapheresis market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Asahi Kasei Corporation; Fresenius SE & Co. KGaA; Haemonetics Corporation; Terumo Corporation; STEMCELL Technologies Inc.; HemaCare; Macopharma; AllCells; STEMEXPRESS; and BioIVT among others.
Reasons to buy report
- To understand the Europe leukapheresis market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe leukapheresis market
- Efficiently plan M&A and partnership deals in Europe leukapheresis market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe leukapheresis market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.
Europe Leukapheresis Market Segmentation
Europe Leukapheresis Market – By Product Type
- Leukapheresis Disposables
- Leukapheresis Devices
Europe Leukapheresis Market – By Application
- Research Applications
- Therapeutic Applications
Europe Leukapheresis Market – By Product Type
- Blood Component Providers and Blood Centers
- Hospitals and Transfusion Centers
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
Europe Leukapheresis Market – By Country
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Europe Leukapheresis Market – Companies Mentioned
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Leukapheresis Market – By Product Type
1.3.2 Europe Leukapheresis Market – By Application
1.3.3 Europe Leukapheresis Market – By End User
1.3.4 Europe Leukapheresis Market – By Country
2. Europe Leukapheresis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Leukapheresis Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. Europe Leukapheresis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Elevating Number of Voluntary Blood Donors
5.1.2 Growing Incidence of Hematologic Diseases
5.1.3 Scaling Elderly Population
5.2 Key Market Restraints
5.2.1 Heavy Cost of Leukapheresis
5.3 Key Market Opportunities
5.3.1 Boosting Opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Advancements in Therapeutic Apheresis
5.5 Impact Analysis
6. Europe Leukapheresis – Market Analysis
6.1 Europe Leukapheresis Market Revenue Forecast and Analysis
7. Europe Leukapheresis Market Analysis – by Product Type
7.1 Overview
7.2 Europe Leukapheresis Market Share by Product Type 2021 & 2028 (%)
7.3 Leukapheresis Devices
7.3.1 Overview
7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Apheresis Devices
7.3.2.1.1 Overview
7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Leukapheresis ColuMillions and Cell Separators
7.3.2.2.1 Overview
7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Leukoreduction Filters
7.3.2.3.1 Overview
7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)
7.4 Leukapheresis Disposables
7.4.1 Overview
7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)
8. Europe Leukapheresis Market Analysis – by Application
8.1 Overview
8.2 Europe Leukapheresis Market Share by Application 2021 & 2028 (%)
8.3 Research Applications
8.3.1 Overview
8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)
8.4 Therapeutic Applications
8.4.1 Overview
8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)
9. Europe Leukapheresis Market Analysis – by End-User
9.1 Overview
9.2 Europe Leukapheresis Market Share by End-User 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)
9.4 Blood Component Providers and Blood Centers
9.4.1 Overview
9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)
9.6 Hospitals and Transfusion Centers
9.6.1 Overview
9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)
10. Europe Leukapheresis Market – Country Analysis
10.1 Overview
10.1.1 Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3 Germany: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.1.1.3.1 Germany: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.1.4 Germany: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.1.5 Germany: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.2 France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 France: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.1.2.1.1 France: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.2.2 France: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.2.3 France: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.3 UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Overview
10.1.1.3.2 UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3 UK: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.1.3.3.1 UK: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.3.4 UK: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.3.5 UK: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.4 Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3 Italy: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.1.4.3.1 Italy: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.4.4 Italy: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.4.5 Italy : Leukapheresis Market, by End User, 2019-2028 (USD Million)
10.1.1.5 Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.3 Spain: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.1.5.3.1 Spain: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.5.4 Spain: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.5.5 Spain: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.6 Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3 Rest of Europe: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.1.6.3.1 Rest of Europe: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.6.4 Rest of Europe: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.6.5 Rest of Europe: Leukapheresis Market, by End User, 2019–2028 (USD Million)
11. Europe Leukapheresis Market – Impact of COVID-19 Pandemic
11.1 Impact Assessment Of COVID-19 Pandemic
12. Europe Leukapheresis Market – Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Asahi Kasei Corporation
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Haemonetics Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Terumo Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 HemaCare
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Macopharma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AllCells
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 STEMEXPRESS
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BioIVT
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany Leukapheresis Market, by D Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Germany: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. France: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 6. France Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 7. France Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. France: Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. UK: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 10. UK Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 11. UK Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. UK: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Italy: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 14. Italy Leukapheresis Market, by Leukapheresis Devices– Revenue and Forecast to 2028 (USD Million)
Table 15. Italy Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Italy: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. Spain: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 18. Spain Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 19. Spain Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 20. Spain: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Europe: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Europe Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Europe Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Europe: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments Done by Companies
Table 26. Inorganic Developments Done by Companies
Table 27. Glossary of Terms, Leukapheresis Market
LIST OF FIGURES
Figure 1. Europe Leukapheresis Market Segmentation
Figure 2. Europe Leukapheresis Market Segmentation, By country
Figure 3. Europe Leukapheresis Market Overview
Figure 4. Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market
Figure 5. Germany to Show Significant Growth During Forecast Period
Figure 6. Europe Leukapheresis Market, Industry Landscape
Figure 7. Europe PEST Analysis
Figure 8. Europe Leukapheresis market impact analysis of driver and restraints
Figure 9. Europe Leukapheresis Market – Revenue Forecast and Analysis (2021- 2028)
Figure 10. Europe Leukapheresis Market Share by Product Type 2021 & 2028 (%)
Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Europe Leukapheresis Market Share by Application 2021 & 2028 (%)
Figure 17. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Europe Leukapheresis Market Share by End-User 2021 & 2028 (%)
Figure 20. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Europe: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)
Figure 25. Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 26. Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in European Country Markets
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe leukapheresis market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution